• EP 161: How large language models can help build immunotherapies with Michelle Teng of Etcembly Ltd.

  • Nov 14 2024
  • Length: 51 mins
  • Podcast

EP 161: How large language models can help build immunotherapies with Michelle Teng of Etcembly Ltd.

Listen for free

View show details

  • Summary

  • In this week’s episode, Patrick is joined by Michelle Teng, ​​CEO and Co-Founder of Etcembly Ltd and Founding Executive Director and Chief Scientific Officer of SynaptixBio. Michelle explains how her team is training large language models (LLMs) to analyze immune system data and how the company’s Long Term Survivor Study is helping identify T-cell profiles associated with sustained cancer remission. She also speaks to her own experience of ultra-rare genetic disease.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about EP 161: How large language models can help build immunotherapies with Michelle Teng of Etcembly Ltd.

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available